Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood.

Journal of Medicinal Chemistry
Jean QuancardAchim Schlapbach

Abstract

The paracaspase MALT1 has gained increasing interest as a target for the treatment of subsets of lymphomas as well as autoimmune diseases, and there is a need for suitable compounds to explore the therapeutic potential of this target. Here, we report the optimization of the in vivo potency of pyrazolopyrimidines, a class of highly selective allosteric MALT1 inhibitors. High doses of the initial lead compound led to tumor stasis in an activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) xenograft model, but this compound suffered from a short in vivo half-life and suboptimal potency in whole blood. Guided by metabolism studies, we identified compounds with reduced metabolic clearance and increased in vivo half-life. In the second optimization step, masking one of the hydrogen-bond donors of the central urea moiety through an intramolecular interaction led to improved potency in whole blood. This was associated with improved in vivo potency in a mechanistic model of B cell activation. The optimized compound led to tumor regression in a CARD11 mutant ABC-DLBCL lymphoma xenograft model.

References

Apr 22, 2006·The Journal of Organic Chemistry·Michael H AbrahamLee Griffiths
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Richard B van Breemen, Yongmei Li
Apr 26, 1963·Science·N K Jerne, A A Nordin
Feb 12, 2008·Nature Immunology·Fabien RebeaudMargot Thome
Mar 8, 2008·Science·Georg LenzLouis M Staudt
Feb 24, 2010·Journal of Medicinal Chemistry·Bernd KuhnMartin Stahl
Jun 29, 2010·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Claudia BrandtRia Baumgrass
Aug 26, 2010·Laboratory Animals·H TønsbergA Müllertz
Apr 28, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Dalila Bachir-CherifFranz Schuler
Mar 1, 2012·Journal of Molecular Biology·Christian WiesmannMartin Renatus
Jan 29, 2013·Journal of Medicinal Chemistry·Fernando PadillaMatthew C Lucas
Aug 16, 2013·Angewandte Chemie·Florian SchlaudererKarl-Peter Hopfner
Sep 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lorena Fontán, Ari Melnick
Jul 22, 2014·Journal of Neuroinflammation·Conor Mc GuireGeert van Loo
Nov 2, 2014·The EMBO Journal·Arianna Bertossi, Daniel Krappmann
Mar 13, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Frédéric BornancinThomas Calzascia
Oct 29, 2015·Cellular and Molecular Life Sciences : CMLS·Maike Jaworski, Margot Thome
Jan 21, 2016·Trends in Molecular Medicine·Annelies DemeyerRudi Beyaert
Apr 18, 2016·Bioorganic & Medicinal Chemistry·Bo-Tao XinHerman S Overkleeft
Oct 29, 2017·Immunology Letters·Adeline UnterreinerFrédéric Bornancin
Jan 24, 2018·Immunology and Cell Biology·Maureen BardetFrédéric Bornancin
May 13, 2018·Bioorganic & Medicinal Chemistry·Guolin WuHaijun Chen
May 16, 2018·Bioorganic & Medicinal Chemistry Letters·Achim SchlapbachJean Quancard
Jan 22, 2019·Journal of Visualized Experiments : JoVE·Adeline UnterreinerFrederic Bornancin
Jan 30, 2019·Nature Chemical Biology·Jean QuancardChristopher M Overall
Apr 14, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Liqing ChengXin Lin
Nov 5, 2019·Bioorganic & Medicinal Chemistry Letters·Tianbao LuJames Edwards
May 20, 2020·Frontiers in Immunology·Kea MartinThomas Calzascia
Dec 1, 2020·Journal of Medicinal Chemistry·Carole Pissot SoldermannCatherine H Régnier

❮ Previous
Next ❯

Citations

Jul 3, 2021·Expert Opinion on Therapeutic Patents·Isabel HampDaniel Krappmann
Nov 13, 2021·Science Immunology·Thomas J O'NeillDaniel Krappmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Lorena Fontan, Ari Melnick
Methods in Molecular Biology
Daniel Nagel, Daniel Krappmann
Current Opinion in Chemical Biology
Stephan HailfingerMargot Thome
© 2021 Meta ULC. All rights reserved